Pfizer, BioNTech to expand Covid vaccine Phase 3 trial
New York: US-based pharmaceutical major Pfizer and German biotech firm BioNTech have announced to expand the enrollment of their Phase 3 Covid-19 vaccine trial to up to approximately 44,000 participants, up from an initial recruitment goal…